Literature DB >> 19747353

Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.

Stephen B Williams1, David W McDermott, Dock Winston, Eamonn Bahnson, Alexander M Berry, Graeme S Steele, Jerome P Richie.   

Abstract

OBJECTIVE: To review differences between primary retroperitoneal lymph node dissection (P-RPLND) and RPLND after chemotherapy (PC-RPLND) in a contemporary series of patients with testicular cancer, to validate the proposed low morbidity. PATIENTS AND METHODS: Patients who had undergone RPLND at our institution in 2001-2008 were identified and their clinical charts reviewed; in all, 190 were identified and perioperative data obtained.
RESULTS: Of the 190 patients who had RPLND, 98 (52%) and 92 (48%) had P- and PC-RPLND, respectively. Histology of the orchidectomy specimen consisted of embryonal carcinoma in 146 (76%) patients, also including lymphovascular invasion in 83 (44%). The mean (range) operative duration was 206 (110-475) min and the mean blood loss was 294 (50-7000) mL. The median hospital stay was 4 days. Mean blood loss, operative duration and hospital stay were significantly less for the P-RPLND than for PC-RPLND groups (P < 0.05). There were 18 (9%) perioperative complications in all. There were no deaths in either group.
CONCLUSIONS: The short-term morbidity of open RPLND is acceptable, and open RPLND is safe and effective at select tertiary centres. When compared with historical data, the present contemporary series shows that the operative duration, blood loss and hospital stay have improved, with few complications. These contemporary data should be considered when comparing laparoscopic with open RPLND.

Entities:  

Mesh:

Year:  2009        PMID: 19747353     DOI: 10.1111/j.1464-410X.2009.08888.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  15 in total

1.  Testicular cancer: Decision tree model has potential to improve NSGCT management.

Authors:  Ornob P Roy; Louis R Kavoussi
Journal:  Nat Rev Urol       Date:  2010-06       Impact factor: 14.432

2.  [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].

Authors:  S Aufderklamm; T Todenhöfer; J Hennenlotter; G Gakis; J Mischinger; J Mundhenk; M Germann; A Stenzl; C Schwentner
Journal:  Urologe A       Date:  2013-08       Impact factor: 0.639

Review 3.  Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.

Authors:  Harsha R Mittakanti; James R Porter
Journal:  Transl Androl Urol       Date:  2020-01

4.  Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.

Authors:  Andrew D Supron; Joseph G Cheaib; Michael J Biles; Zeyad Schwen; Mohamad Allaf; Phillip M Pierorazio
Journal:  J Robot Surg       Date:  2020-06-22

5.  Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?

Authors:  C Overs; J B Beauval; L Mourey; P Rischmann; M Soulié; M Roumiguié; Nicolas Doumerc
Journal:  World J Urol       Date:  2018-01-20       Impact factor: 4.226

6.  Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.

Authors:  Kathleen Kieran; James R Anderson; Jeffrey S Dome; Peter F Ehrlich; Michael L Ritchey; Robert C Shamberger; Elizabeth J Perlman; Daniel M Green; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2012-04       Impact factor: 2.545

7.  Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.

Authors:  Nicholas R Rocco; Sean P Stroup; Haidar M Abdul-Muhsin; Michael T Marshall; Michael G Santomauro; Matthew S Christman; James O L'Esperance; Erik P Castle
Journal:  World J Urol       Date:  2019-09-09       Impact factor: 4.226

8.  Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.

Authors:  Hiten D Patel; Gregory A Joice; Zeyad R Schwen; Alice Semerjian; Ridwan Alam; Arnav Srivastava; Mohamad E Allaf; Phillip M Pierorazio
Journal:  World J Urol       Date:  2017-10-12       Impact factor: 4.226

9.  Reimbursements and frequency of tests in privately insured testicular cancer patients in the United States: Implications to national guidelines.

Authors:  Mohamed H Kamel; Austin Barber; Rodney Davis; Omer A Raheem; Nabil Bissada; Alaa Eldin A Abdelmaksoud; Ehab Eltahawy
Journal:  Urol Ann       Date:  2017 Apr-Jun

Review 10.  A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Authors:  Zeyad R Schwen; Mohit Gupta; Phillip M Pierorazio
Journal:  Adv Urol       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.